BE studies (bioequivalence studies)

Bioequivalence (BE) studies are research tests that compare two versions of the same medication to ensure they deliver the same amount of active ingredient into the bloodstream at the same rate. Typically, they assess a brand-name drug against a generic version to verify that the generic works just as effectively and safely. These studies involve healthy volunteers who take both versions in controlled settings, and the results confirm that the alternative medication is a suitable substitute without compromising quality or effectiveness. BE studies are essential for regulatory approval and ensuring patient trust in generic medicines.